COPD readmissions reduction program decreases 30-day hospital readmission, may increase mortality - UTMB Newsroom, Sept 10, 2020

Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.

The findings are currently available in the American Journal of Respiratory and Critical Care Medicine.

Authors:

• Daniel A Puebla Neira , Pulmonary Medicine and Critical Care
• En Shuo Hsu , Department of Biostatistics
• Yong-Fang Kuo , Critical Care & Sleep Medicine
• Kenneth J. Ottenbacher , Division of Rehabilitation Sciences
• Gulshan Sharma , Pulmonary, Critical Care and Sleep Medicine

More News About these Findings:

HRRP Tied to Decrease in 30-Day Readmission Rates for COPD- Drugs.com, Sept. 24, 2020

The use of the Hospital Readmissions Reduction Program may help reduce the 30 day readmission rate of COPD patients but it may also increase mortality, according to a new study. UTMB’s Daniel A. Puebla Neira and colleagues looked at data from over 4 million Medicare patients. "Further research is needed to confirm our findings and identify factors contributing to the increased mortality seen in patients with COPD in the Centers for Medicare & Medicaid Services readmission reduction program," Puebla Neira said in a statement. This news also reported in Physician's Weekly, Doctors Lounge and Physician Briefings.